These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 13216050)

  • 1. [Tuberculous leptomeningomyelitis with spinal block in meningeal tuberculosis during streptomycin therapy].
    SEGA E
    Riv Anat Patol Oncol; 1953 Nov; 7(6):751-72. PubMed ID: 13216050
    [No Abstract]   [Full Text] [Related]  

  • 2. [The number and type of cerebrospinal fluid cells and the passage of streptomycin into the spine during therapy of tuberculous meningitis by the Boschi-Speransky-Madon diencephalo-spinal method].
    DURANDO E; LORENZI L
    Minerva Pediatr; 1955 Mar; 7(9):273-7. PubMed ID: 14369911
    [No Abstract]   [Full Text] [Related]  

  • 3. [Tuberculous meningitis and its therapy with streptomycin; cytology of the cerebrospinal fluid].
    TASOVAC B; CALIC N; JAKOVLJEV D; DJUKIC D
    Srp Arh Celok Lek; 1954 Dec; 82(12):1619-27. PubMed ID: 14396602
    [No Abstract]   [Full Text] [Related]  

  • 4. [Principles of dia-cerebrospinal therapy applied to streptomycin therapy of tuberculous meningitis; cure in all cases].
    BOSCHI G
    G Ital Chemioter; 1954; 1(3-4):551-3. PubMed ID: 14391666
    [No Abstract]   [Full Text] [Related]  

  • 5. [Spinal block in streptomycin therapy of tuberculous meningitis].
    MAJEWSKA Z
    Neurol Neurochir Psychiatr Pol; 1955; 5(5):533-50. PubMed ID: 13297109
    [No Abstract]   [Full Text] [Related]  

  • 6. Contribution to the physiopathology of the cerebrospinal fluid. I. Residual nitrogen in cerebrospinal fluid during tuberculous meningitis treated with streptomycin.
    CALANDI C; PERITI P
    Riv Clin Pediatr; 1953 Aug; 52(2):87-99. PubMed ID: 13121870
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cytological and chemical changes in the cerebrospinal fluid during streptomycin therapy of tuberculous meningitis].
    KUKOLEWSKA J
    Pediatr Pol; 1952 Dec; 27(12):1381-96. PubMed ID: 13046939
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pyocyaneous meningitis during intrathecal streptomycin and hydrocortisone therapy of four cases of tuberculous meningitis].
    BARUH SH; PAPAZYAN O; OZKAN E; ERDOGAN G; ERDEM K
    Turk Tip Cemiy Mecm; 1957 Oct; 23(10):544-59. PubMed ID: 13530265
    [No Abstract]   [Full Text] [Related]  

  • 9. [Deafness and spinal block; complications of streptomycin treatment of meningeal tuberculosis].
    AUBERTIN E; DULONG DE ROSNAY C; LABADIE P
    J Med Bord; 1953 Jun; 130(6):785-93. PubMed ID: 13096983
    [No Abstract]   [Full Text] [Related]  

  • 10. Mode of action of streptomycin in relation to the changes in spinal fluid sugar in tuberculous meningitis. I. The role of streptomycin as a reducing agent and the specificity of the Shaffer-Hartmann method for determining true glucose when the antibiotic is used; in vitro experiments.
    FRIEDMAN RH; HARTMANN AF
    J Pediatr; 1953 Feb; 42(2):157-60. PubMed ID: 13023514
    [No Abstract]   [Full Text] [Related]  

  • 11. [Streptomycin levels in cerebrospinal fluid in relation to possible enzyme action or changes in meningeal permeability during therapy of meningeal tuberculosis].
    PANI A
    Minerva Med; 1953 May; 44(41):1361-8. PubMed ID: 13072057
    [No Abstract]   [Full Text] [Related]  

  • 12. [Mental disorders during streptomycin treated tuberculous meningitis].
    RISTIC J
    Rev Neurol (Paris); 1954; 90(6):797-803. PubMed ID: 13237767
    [No Abstract]   [Full Text] [Related]  

  • 13. [The problem of pathogenicity and localization of cochlear and vestibular disorders occurring in the course of streptomycin therapy; with reference to 3 cases of tuberculous meningitis].
    TERRIER G
    Schweiz Arch Neurol Psychiatr; 1953; 72(1-2):331-61. PubMed ID: 13168271
    [No Abstract]   [Full Text] [Related]  

  • 14. [Case of acquired imbecility; the result of streptomycin therapy in tuberculous meningitis].
    EGELUND G
    Ugeskr Laeger; 1955 Nov; 117(45):1461-3. PubMed ID: 13299389
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cochleo-vestibular disorders in tuberculous meningitis treated with streptomycin].
    POPELIANSKII IaIu
    Vestn Otorinolaringol; 1954; 16(5):16-20. PubMed ID: 13217165
    [No Abstract]   [Full Text] [Related]  

  • 16. [Visual disturbances in children with tuberculous meningitis treated with streptomycin].
    LICHT E; PAPROCKA L
    Pediatr Pol; 1952 Dec; 27(12):1397-406. PubMed ID: 13046940
    [No Abstract]   [Full Text] [Related]  

  • 17. Mode of action of streptomycin in relation to the changes in spinal fluid sugar in tuberculous meningitis. I. Observations on the effect of intrathecal streptomycin treatment on the cerebrospinal fluid sugar in tuberculous meningitis.
    FRIEDMAN RH; THURSTON DL; HARTMANN AF
    J Pediatr; 1953 Feb; 42(2):161-70. PubMed ID: 13023515
    [No Abstract]   [Full Text] [Related]  

  • 18. [Atrophy of the optic nerve during streptomycin therapy of tuberculous meningitis].
    STOENCHEV SP
    Suvr Med (Sofiia); 1955; 6(8):90-4. PubMed ID: 13299074
    [No Abstract]   [Full Text] [Related]  

  • 19. [Blood and cerebrospinal fluid quotient of streptomycin and its prognostic value in tuberculous meningitis].
    GOMIRATO-SANDRUCCI M
    Minerva Pediatr; 1953 Nov; 5(22):993-1001. PubMed ID: 13144593
    [No Abstract]   [Full Text] [Related]  

  • 20. [Determination of streptomycin levels in blood, cerebrospinal fluid and brain in tuberculous meningitis].
    LAUR O; OTTE HJ
    Z Tuberk; 1952 Sep; 100(6):350-6. PubMed ID: 13006929
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.